| From my understanding, the last budget bill passed (called the big beautiful bill by some) had changes to section 174. Specifically that software R&D could once again be immediately fully expensed in the year incurred rather than amortized over several years SO LONG AS its a US based expense. Non US based R&D expenses still need to be amortized, and over an ugly 15 year period. What significant changes to section 174 were made in the big beautiful bill? Key Changes
The bill created a new Section 174A that restores immediate deductibility for domestic research and experimental (R&E) expenditures, largely reversing the Tax Cuts and Jobs Act requirement that had forced companies to capitalize and amortize all R&E expenses starting in 2022. Domestic vs. Foreign Treatment: Starting with tax years beginning after December 31, 2024, businesses may immediately deduct domestic R&E expenditures in the year they are paid or incurred Foreign R&E expenditures must continue to be capitalized and amortized over 15 years under the original Section 174 Retroactive Relief Options: The new rules permit taxpayers to deduct previously capitalized and unamortized domestic R&E expenditures over a one- or two-year period, and small businesses may opt to apply new Section 174A going back to 2022 and file amended returns. Eligible small business taxpayers (generally those with average annual gross receipts during the preceding three years not exceeding $31 million) can retroactively expense R&E expenditures for taxable years beginning after December 31, 2021, by filing amended returns. Alternative Treatment: Taxpayers may still elect to capitalize and amortize domestic R&E expenditures over a period of not less than 60 months, or elect to amortize them over a 10-year period. This represents a major win for businesses conducting research and development, as the 2022-2024 capitalization requirement had created significant tax burdens and compliance complexity. |